Quick Comparison

PEA (Palmitoylethanolamide)Zinc
Half-Life1-2 hours (rapidly metabolized). Micronized forms have improved bioavailabilityTissue zinc turns over over weeks
Typical DosageStandard: 300-1200 mg daily in 2-3 divided doses. Start at 600 mg daily. Micronized or ultra-micronized (um-PEA) forms have much better absorption. For chronic pain: 600 mg twice daily. For neuroinflammation: 400-600 mg twice daily. Effects build over 2-4 weeks.Standard: 15-30 mg elemental zinc daily. Do not exceed 40 mg daily long-term (can cause copper depletion). Zinc picolinate, zinc bisglycinate, and zinc carnosine are well-absorbed forms. Zinc oxide is poorly absorbed. Take with food to reduce nausea. If supplementing >15 mg daily, add 1-2 mg copper.
AdministrationOral (capsules, powder). Micronized (m-PEA) or ultra-micronized (um-PEA) forms preferred for bioavailability.Oral (capsules, tablets, lozenges). Take with food. Zinc picolinate or bisglycinate for best absorption.
Research Papers10 papers9 papers
Categories

Mechanism of Action

PEA (Palmitoylethanolamide)

PEA activates PPAR-alpha (peroxisome proliferator-activated receptor alpha), a nuclear receptor that heterodimerizes with RXR and downregulates pro-inflammatory gene expression (NF-kB target genes, COX-2, iNOS, TNF-alpha). It has an 'entourage effect' on the endocannabinoid system — it inhibits the degradation of anandamide by fatty acid amide hydrolase (FAAH) through allosteric modulation or substrate competition, and upregulates CB2 receptor expression on immune cells. This provides anti-inflammatory and analgesic effects without directly activating CB1/CB2. PEA also activates GPR55 and GPR119. It inhibits mast cell degranulation (reducing histamine, tryptase, and cytokine release) and reduces microglial activation in the brain (inhibiting Iba1 expression and pro-inflammatory cytokine production). PEA may also modulate TRPV1.

Zinc

Zinc is released from synaptic vesicles (via ZnT3 transporter) during neurotransmission from glutamatergic mossy fiber and Schaffer collateral terminals. It modulates NMDA receptors — at high concentrations zinc blocks the channel at a distinct site from Mg2+, while at low concentrations it potentiates via the GluN2A subunit. Zinc modulates GABA-A receptors (positive allosteric at alpha1, negative at alpha2/3) and glycine receptors. It is required for BDNF synthesis (zinc finger transcription factors) and TrkB signaling. Zinc-dependent enzymes include carbonic anhydrase (CAII, pH regulation), Cu/Zn superoxide dismutase (SOD1, antioxidant defense), and matrix metalloproteinases (synaptic remodeling). In the hippocampus, zinc modulates long-term potentiation (LTP) via CaMKII and MAPK/ERK pathways — the cellular basis of memory formation. Zinc also regulates presynaptic vesicle release.

Risks & Safety

PEA (Palmitoylethanolamide)

Common

Very well-tolerated — rare side effects. Mild GI discomfort.

Serious

None documented. Over 30 clinical trials confirm excellent safety profile.

Rare

Skin rash.

Zinc

Common

Nausea on empty stomach, metallic taste.

Serious

Long-term high-dose use (>40 mg daily) depletes copper, causing anemia and neurological problems.

Rare

Headache, diarrhea, reduced immune function (paradoxically) at very high doses.

Full Profiles